Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation - Trial 2016-004957-33
Access comprehensive clinical trial information for 2016-004957-33 through Pure Global AI's free database. This phase not specified trial is sponsored by Eisai Korea Inc. and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2016-004957-33
Trial Details
EU Clinical Trials Register • 2016-004957-33
Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation
Study Focus
Sponsor & Location
Eisai Korea Inc.
Eisai Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Percentage of Participants With Seizure Free Rate
ICD-10 Classifications
Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus
Data Source
EU Clinical Trials Register
2016-004957-33
Non-Device Trial